USDM’s Guide to 21 CFR Part 11 Learn about 21 CFR Part 11, the FDA regulation ensuring the security, traceability, and compliance of electronic records and eSignatures in life sciences. David Blewitt - April 14, 2024 Blogs Biotech, CMO, CRO, Medical Device, Pharma Regulatory
Fast-Track Your Journey to Commercialization Fast-track commercialization in life sciences with USDM's GxP expertise, IT strategies, and QMS frameworks for compliance, efficiency, and success. Lisa Om - March 25, 2024 Blogs Biotech Clinical
Enhancing Regulatory Compliance for a Pharmaceutical Manufacturing Company Learn how USDM seamlessly validated DocuSign for a Pharmaceutical Manufacturing Company. Nithya Sittaramane - August 24, 2023 Case Studies Pharma Information Technology
Streamline Document Signing with Built-In Continuous Compliance Learn how USDM validated DocuSign for a biotech company with a remote workforce, enhancing efficiency and flexibility. Nithya Sittaramane - June 21, 2023 Case Studies Biotech Information Technology, Regulatory
GxP System Validation and Monitoring for Half the Cost Learn how an emerging therapeutics company saves more than $400k annually and maintains SaaS systems for half that cost. Lisa Om - June 6, 2023 Case Studies Biotech Information Technology
eSignature Transforms Workflows for Leading Biotech Company Learn how a leading biotech company improved efficiencies and saved costs with Cloud Assurance for DocuSign. Nithya Sittaramane - April 13, 2023 Case Studies Biotech Regulatory
